CORONAVIRUS: WILL THE WORLD BENEFIT FROM ANTIBODY THERAPIES?

Ledford Heidi

首页> 外文期刊>Nature >CORONAVIRUS: WILL THE WORLD BENEFIT FROM ANTIBODY THERAPIES?

【24h】

CORONAVIRUS: WILL THE WORLD BENEFIT FROM ANTIBODY THERAPIES?

机译：冠状病毒：世界是否会受益于抗体疗法？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Monoclonal antibodies are complex and expensive to produce, meaning poor countries might be priced out.Monoclonal antibodies are complex and expensive to produce, meaning poor countries might be priced out.

机译：单克隆抗体复杂，生产昂贵，意味着贫穷的国家可能被淘汰。Monoclonal抗体复杂，产生昂贵，意味着贫穷的国家可能被定价。

著录项

来源
《Nature》 |2020年第7821期|333-334|共2页
作者
Ledford Heidi;
展开▼
作者单位

展开▼
收录信息美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
原文格式 PDF
正文语种 eng
中图分类
关键词
Policy; SARS-CoV-2; Medical research; Infection;

机译：政策;SARS-COV-2;医学研究;感染;

相似文献

外文文献
中文文献
专利

1. Novel combination therapy, TAS-102 combined with the anti-EGFR antibody or the anti-VEGF antibody showed therapeutic benefit toward colorectal cancer xenografts [J] . Ishida K., Sakamoto K., Tanaka N., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2014,第Suppla6期

机译：TAS-102与抗EGFR抗体或抗VEGF抗体联合的新型联合疗法对结直肠癌异种移植物显示出治疗效果
2. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19) [J] . Shanmugaraj Balamurugan, Siriwattananon Konlavat, Wangkanont Kittikhun, Ecological restoration . 2020,第1期

机译：单克隆抗体治疗的透视作为冠状病毒疾病-19的潜在治疗干预（Covid-19）
3. Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets [J] . van Doremalen Neeltje, Falzarano Darryl, Ying Tianlei, Antiviral Research . 2017,第期

机译：基于抗体疗法对中东呼吸综合征Coronavirus（MERS-COV）的疗效
4. Impaza, an Oral Antibody Therapeutic for Erectile Dysfunction: Benefits from Mono- and Combine Therapy [C] . A. Martyushev-Poklad, E. Mazo, S. Gamidov, International Congress of Andrology . 2005

机译：Impaza，一种口腔抗体治疗用于勃起功能障碍的疗效：来自单次和结合治疗的益处
5. Development of human monoclonal antibodies against infectious disease: SARS-associated coronavirus and avian influenza. [D] . Leung, Ka Man. 2009

机译：抗传染病的人类单克隆抗体的开发：SARS相关冠状病毒和禽流感。
6. Complication of coronavirus disease 2019 during remission induction therapy against anti-MDA5 antibody-positive dermatomyositis [O] . Masahiro Kogami, Satoshi Suzuki, Yuta Nanjo, 2020

机译：对抗MDA5抗体阳性皮肤肌炎缓解诱导治疗冠状病毒疾病的并发症
7. Therapeutic Plasma Exchange–Neutralizing Antibody Combination Therapy for Severe Coronavirus Disease 2019 [O] . Miroslav Malkovsky 2020

机译：治疗血浆交换中和抗体联合治疗2019年严重冠状病毒疾病

CORONAVIRUS: WILL THE WORLD BENEFIT FROM ANTIBODY THERAPIES?

摘要

著录项

相似文献

相关主题

期刊订阅